Trump wants Congress to make his drug pricing deals law. It won’t be easy.
Analysis Summary
This article uses quotes from conservative figures and lobbyists to suggest that codifying Trump's drug pricing deals is complicated and unlikely to pass. It relies on vague criticisms, primarily by omitting details about the actual drug deals, which encourages readers to be skeptical of the proposals without fully understanding them.
FATE Analysis
Four dimensions of psychological manipulation: how content captures Focus, exploits Authority, triggers Tribal identity, and engineers Emotion.
Focus signals
"Conservative groups have already been exerting pressure against codification, with more than 50 leaders of GOP and free-market groups signing a letter to Congress arguing that turning the drug pricing deals into law would “import socialist price controls and values into our country.”"
While this is a factual report, the framing of 'exerting pressure against codification' combined with the 'socialist price controls' claim presents a novel and potentially alarming development that could grab a reader's attention.
Authority signals
"Conservative groups have already been exerting pressure against codification, with more than 50 leaders of GOP and free-market groups signing a letter to Congress arguing that turning the drug pricing deals into law would “import socialist price controls and values into our country.”"
The article uses the broad 'Conservative groups,' 'GOP and free-market groups,' and 'Congress' as authoritative entities to lend weight to the claims being made against codification, suggesting that these powerful bodies are unified in their concerns.
"Nick Shipley, a longtime drug industry lobbyist who previously worked for both the Biotechnology Innovation Organization and PhRMA, the Washington lobbies for drugmakers, questioned if Republicans on Capitol Hill will have much appetite to take Trump up on that request."
Shipley's extensive background as a 'longtime drug industry lobbyist' and his work for major lobbying groups are presented as credentials to frame him as an expert whose opinion on congressional appetite for Trump's request should be taken seriously.
"Pharmaceutical Research and Manufacturers of America CEO Stephen Ubl has thrown cold water on the idea that the brand drug industry is ready to support codifying anything that resembles Trump’s most-favored nation deals."
Stephen Ubl's title as CEO of a major pharmaceutical lobbying group establishes him as an authoritative voice directly representing the industry's stance, discouraging the idea of support for the proposed deals.
"CMS Administrator Mehmet Oz asked drugmakers at their annual forum last week to work with the Trump administration to codify the confidential deals."
The mention of 'CMS Administrator Mehmet Oz' and 'Trump administration' leverages the authority of government and a well-known public figure to advocate for codification, suggesting institutional backing for the proposition.
Tribe signals
"Conservative groups have already been exerting pressure against codification, with more than 50 leaders of GOP and free-market groups signing a letter to Congress arguing that turning the drug pricing deals into law would “import socialist price controls and values into our country.”"
The phrase 'import socialist price controls and values into our country' clearly establishes an 'us' (our country, free-market values) versus 'them' (socialist values) dynamic, weaponizing political ideology to create division.
"Is it a free market when the U.S. taxpayer funds research and development for a drug, that drug is produced here and then we sell it to other countries for a fraction of what we charge our own citizens?"
Senator Moreno's quote challenges the 'free market' identity cherished by many Republicans, suggesting that current practices are inconsistent with this core tribal belief. This questions the ideological purity of those who might oppose codification.
"If we are talking about a socialist market like they have in France clearly that is not who we are, but that is not what he is proposing either.”"
Senator Lankford creates an 'us' ('not who we are') versus 'them' (France, 'socialist market') dichotomy, drawing a clear line between American identity and a perceived negative foreign economic model.
Emotion signals
"Is it a free market when the U.S. taxpayer funds research and development for a drug, that drug is produced here and then we sell it to other countries for a fraction of what we charge our own citizens?"
This rhetorical question is designed to elicit outrage and indignation from readers who might feel unfairly treated or robbed as taxpayers and citizens paying more for drugs than other nations.
"Conservative groups have already been exerting pressure against codification, with more than 50 leaders of GOP and free-market groups signing a letter to Congress arguing that turning the drug pricing deals into law would “import socialist price controls and values into our country.”"
The phrase 'import socialist price controls and values into our country' is designed to trigger fear and anxiety around a perceived threat to America's economic system and national identity.
Narrative Analysis (PCP)
How the article reshapes thinking: Perception (what beliefs are targeted), Context (what information is shifted or omitted), and Permission (what behavior is being encouraged).
The article aims to instill the belief that codifying Trump's drug pricing deals is complex, faces significant political hurdles, and lacks broad consensus, making it an unlikely or difficult endeavor. It also suggests that alternative, less controversial reforms (like those targeting PBMs) might be more viable.
The article shifts the context from simply 'lowering drug costs' to 'lowering drug costs via Trump's specific, confidential, and potentially 'socialist' most-favored-nation deals.' This shift introduces skepticism and political partisanship into a discussion that might otherwise be framed as a universally desirable goal.
The article omits detailed explanations of what Trump's 'most-favored-nation' drug pricing deals actually entailed, beyond vague references to 'lowering U.S. drug costs closer to what other countries pay' and 'confidential deals.' This lack of detail regarding the specific mechanisms and potential impacts of the deals allows fears of 'socialist price controls' and concerns about secrecy to hold greater sway, as readers cannot fully evaluate the proposals on their merits. For example, it doesn't explain how the pricing was determined, what specific drugs were affected, or the actual economic impact of the previous deals.
The reader is nudged toward skepticism regarding the codification of Trump's drug pricing deals, and potentially, to accept that such an effort is unlikely to succeed or is not the most pragmatic path forward. They are also subtly encouraged to consider or support alternative drug pricing reforms, particularly those targeting pharmacy benefit managers (PBMs), as a more feasible bipartisan solution.
SMRP Pattern
Four manipulation maintenance tactics: Socializing the idea as normal, Minimizing concerns, Rationalizing with logic, and Projecting blame.
"Democrats who otherwise may support permanently lowering U.S. drug costs closer to what other countries pay — the aim of most-favored-nation deals — will undoubtedly be reluctant to hand Trump a win while they are hammering him on the cost of living ahead of the fall midterms."
Red Flags
High-severity indicators: silencing dissent, coordinated messaging, or weaponizing identity to shut down debate.
""There’s a strong argument to be made to grab something from people who are proven trustworthy, to get something that you own, you crafted in a way that can preserve the needs of industry while not hurting the American people," Oz said."
""If we are talking about a socialist market like they have in France clearly that is not who we are, but that is not what he is proposing either.""
Techniques Found(6)
Specific propaganda techniques identified using the SemEval-2023 academic taxonomy of 23 techniques across 6 categories.
"import socialist price controls and values into our country."
This phrase uses emotionally charged words like 'socialist' to associate the policy with a negative political ideology, aiming to elicit a negative reaction from the audience without empirical evidence.
"Is it a free market when the U.S. taxpayer funds research and development for a drug, that drug is produced here and then we sell it to other countries for a fraction of what we charge our own citizens?"
This question presents a false dichotomy, implying that either the current system is a free market despite high drug prices for citizens, or codification is the only alternative, ignoring other potential market solutions or regulatory approaches.
"If we are talking about a socialist market like they have in France clearly that is not who we are, but that is not what he is proposing either."
The phrase 'socialist market like they have in France clearly that is not who we are' uses 'socialist' as a negative label and 'not who we are' to appeal to American identity and perceived values, aiming to reject a policy by associating it with a disliked political system.
"I’m not paying more than I pay in Europe. It didn’t make any sense to me at the time, it doesn’t make any sense to me today."
This quote exaggerates the disparity in drug prices (or at least implies a significant, illogical difference) to justify the speaker's stance, framing the current situation as absurd.
"The reality is ever since Trump won when it comes to doing the nuts and bolts of putting together the legislation there ends up being no there there."
This quote, from Senator Wyden, casts doubt on Trump's ability or genuine intent to translate his proposals into concrete legislation, subtly questioning his effectiveness without directly attacking his character.
"There’s a big difference between voluntary agreements and individual companies having discussions with the administration and codifying, on a broad basis, price controls in legislation"
This statement uses vague terminology like 'voluntary agreements,' 'discussions,' and 'codifying, on a broad basis, price controls' to minimize the actual impact or nature of the proposed codification, making it sound more onerous than simply formalizing existing agreements.